Appendix Table 8.
Time to Loss to Follow-up | HR | 95% CI | P Value |
---|---|---|---|
Integrase strand transfer inhibitor use | 0.58 | 0.52–0.64 | <0.001 |
Female | 0.90 | 0.80–1.02 | 0.113 |
Age (per decade, centered at 40 y) | 0.87 | 0.83–0.90 | <0.001 |
Race/ethnicity (reference is white race) | |||
Black | 0.87 | 0.78–0.96 | 0.008 |
Hispanic | 0.69 | 0.62–0.78 | <0.001 |
Other | 0.93 | 0.77–1.12 | 0.45 |
Calendar time (year of cohort entry, centered around 2010) | 1.15 | 1.12–1.18 | <0.001 |
Adherence | 1.00 | 1.00–1.00 | 0.61 |
Cocaine/crack use | 1.00 | 0.85–1.17 | 0.99 |
Methamphetamine/crystal methamphetamine use | 1.01 | 0.88–1.16 | 0.87 |
Opiate/heroin use | 1.10 | 0.85–1.42 | 0.46 |
Marijuana use | 1.08 | 0.99–1.18 | 0.074 |
Hazardous alcohol use | 1.46 | 1.33–1.60 | <0.001 |
HR = hazard ratio.